Telephone Whatsapp
NABH Accredited NABL Accredited ISO Certified
NABH Accredited NABL Accredited ISO Certified

NOTCH3 MUTATION DETECTION; CADASIL (N174)

OUTSOURCE

NOTCH3 MUTATION DETECTION; CADASIL (N174)

Also Known As: NOTCH 3 Mutation Detection CADASIL
₹10,640
Enquire Now
Autosomal dominant cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a progressive disorder of the small arterial vessels of the brain, manifested as migraine, strokes, and white matter lesions, with resultant cognitive impairment in some patients. Autosomal dominant cerebral arteriopathy with subcortical infarcts and leukoencephalopathy type 1 (CADASIL1) is caused by heterozygous mutations in the NOTCH3 gene on chromosome 19p13. The disorder is characterized by relapsing strokes with neuropsychiatric symptoms and affects relatively young adults of both sexes. This test is useful for hot spot mutation screening of exon 3, 4, 5 and 6 of the NOTCH3 gene.
Home Collection
Available
Report TAT
1 Day
Category
OUTSOURCE
View All 1 Parameters
  • NOTCH3 MUTATION DETECTION; CADASIL
1. What Is outsourced test ?
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
2. Any Preparation for the test ?
Physician prescription is mandatory.
3. Why this test is important ?
NOTCH3 Mutation Detection (CADASIL test) is important because it helps confirm the diagnosis of CADASIL, a hereditary disorder affecting small blood vessels of the brain.

The Turnaround Time (TAT) depends on the following factors:

  • Registration date and time
  • Type of scan or test
  • Scan time or sample collection time

In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.

Not sure which test to book?

Talk to our team — we'll guide you to the right diagnostic service in minutes.